Henry Ford Hospital Medical Journal
Volume 40

Number 1

Article 21

3-1992

The Epidemiology of Prostate Cancer in Black Men
David A. Burks
Ray H. Littleton

Follow this and additional works at: https://scholarlycommons.henryford.com/hfhmedjournal
Part of the Life Sciences Commons, Medical Specialties Commons, and the Public Health Commons

Recommended Citation
Burks, David A. and Littleton, Ray H. (1992) "The Epidemiology of Prostate Cancer in Black Men," Henry
Ford Hospital Medical Journal : Vol. 40 : No. 1 , 89-92.
Available at: https://scholarlycommons.henryford.com/hfhmedjournal/vol40/iss1/21

This Article is brought to you for free and open access by Henry Ford Health System Scholarly Commons. It has
been accepted for inclusion in Henry Ford Hospital Medical Journal by an authorized editor of Henry Ford Health
System Scholarly Commons.

The Epidemiology of Prostate Cancer in Black Men

David A. Burks, MD,* and Ray H. Littleton, MD*

Data on the epidemiology of prostate cancer from the 1930s to the present document a dramatic
racial difference in incidence, survival, and mortality rates in American men. American black men
have the highest incidence and mortality rates of prostate cancer in Ihe world. Survival data have
heen related to access lo medical care, genetic and environmental factors, and cultural differences,
including diet and social hahns. Most reports present conflicting data with no clear positive
correlations, and conclusions are often speculative. Better controUed, prospective studies of
epidemiologic variables and a comprehensive genetic evaluation of black families with prostate
cancer are needed to better understand the racial disparity affecting American black men and the
biology ofthis disease in all men. (Henry Ford Hosp Med J 1992:40:89-92)

T

he incidence and mortality rate of prostate cancer in black
men has been increasing since the 1950s and is higher than
that of any other group in America, Three national cancer surveys, four registries in the Surveillance, Epidemiology and End
Results (SEER) of the National Cancer Institute, and surveys
done by the American College of Surgeons provide a data base
from 1949 to the present. Black men have an 85% greater
chance of being diagnosed with prostate cancer and a 114%
greater chance of dying from it than white men (1). The increased mortality rate is explained in part by the increased incidence, but a survival disadvantage is strongly suggested. Despite increased efforts and advances in early detection and
screening, blacks still present with advanced disease 40% more
often than whites.
Numerous investigators have evaluated mulriple factors
which include socioeconomic status, diet, hormones, occupational exposure, and infectious agents in an attempt to identify
risk factors. Results are variable and often conflicting. We review the epidemiological data and explore new concepts regarding genetic and environmental factors that may shed some light
on this malignant epidemic in the black community.

Temporal Trends
Three nafional cancer surveys, conducted in 1937-1939,
1947-1948, and 1969-1971, show a marked increase in the annual incidence of prostate cancer in blacks when compared to
whites. This racial disparity occurs in all age groups and parallels mortality rate trends. From the 1937-1939 survey to the
1969-1971 survey, the incidence of prostate cancer increased
53.3% for whites and 151.6% for blacks for alt ages, adjusted to
the 1950 U.S. populationfigures(2). This dramatic racial disparity is emphasized in the third national cancer survey (TNCS),
from 1969-1971, which found that for the first time the incidence of prostate cancer in blacks is higher than the incidence of
lung cancer (94.9 versus 89.9 per 100,000 population) (2).
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More recent evaluations continue to show these trends. From
1973 to 1981 the SEER program evaluated data on black patients, principally from Detroit, Atlanta, and the San FranciscoOakland area. From 1978 to 1981, the average annual age-adjusted incidence of prostate cancer was 120.3 per 100,000, up
from 94.9, a 26.8% increase in 10 years. This compares with the
increase in white men from 57.7 to 75.1 per 100,000 during the
same period (3).
Data since 1981 continue to document the disparity. The
SEER 1985 report, adjusted to 1970 census standards, shows an
incidence of 512.2 per 100,000 population for atl cancer sites in
black males versus 422.4 for white mates, a 21% higher incidence For prostate cancer only, the rate was 127.6 for black
males and 84.9 for white mates, a 50% higher incidence for
blacks (4). The gap, therefore, is widening with time.
Age at presentation
Using the TNCS data, in each age group, except for the
youngest and oldest patients, incidence rates for blacks are
higher than for whites. On average for blacks, the incidence
curve by age was shifted 5 years eariier than for whites. Occurrence of prostate cancer for both groups increased with age but
the rate of increase occurs earlier for blacks (2),
Stage at presentation
Jackson et al (5) reported on 231 black patients with prostate
cancer studied in Washington, DC, from 1973 to 1978. A total
of 51 % had stage 1 or 2 (localized) disease Only 4.4% had stage
3 disease (regional spread), and 44.9% had metastatic disease at
presentation.
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SEER data from 1974-1985 for San Francisco-Oakland, Atlanta, Detroit, and Connecticut showed that, for both races, the
percentage of patients presenting at each disease stage remained
constant over time, but blacks were consistently 40% more
likety to present with distant metastasis (27.5%) than were
whites (19.4%) (4), This disparity was confirmed by the American College of Surgeons study (1) which evaluated more than
1,000 patients in 1974 and 1983. The study concluded that
metastatic disease presented initially in black males 60% more
frequently than in white males for both years. This is the most
important fact in translating incidence data into mortality data,
but it cannot account for the entire increase in mortality.
Geographic distribution
Geographic differences in the incidence of prostate cancer are
difficult to evaluate because standards of medical care, demographic features, and accuracy of reporting vary substantially
from region to region. Higher incidence rates for blacks have
been reported in the Southwest, Midwest, and Northeast when
the analysis was done by counties which are more homogeneous
than are states. By contrast, whites had a higher incidence rate in
the upper Midwest states and in the New England areas. There
was no reported significant difference between urban and rural
areas, with the exception of farmers (2).
The TNCS, 1969-1971, showed no statistically significant
age-adjusted difference in incidence by geographic area for
blacks, although the survey did not cover every state or city (6).
Colorado, the Dallas-Fort Worth area, the San FranciscoOakland area, and Detroit had the highest incidence.
Mortality data
Age-adjusted mortality rates for prostate cancer in U.S. black
men have alsorisendramatically since 1955. The racial disparity with U.S. white men has become an epidemiologic characteristic of the disease and forms the rationale for studies on environmental or life-style factors. Thetimeperiod seems too short
for genetic mechanisms to be entirely responsible.
American blacks have the highest age-adjusted mortality rate
for prostate cancer on earth. From 1930-1974, there was a
33.6% mortality increase among whites but a 322% increase
(adjusted to the 1950 census) among nonwhites (predominantly
blacks). Most of this increase occurred in blacks over age 75,
whereas the mortality rates in whites leveled off after age 75 (2).
In 1985, SEER data from San Francisco-Oakland, Detroit, Atlanta, and Connecticut, adjusted to the 1970 U.S. population
census, revealed a death rate of 21.9 per 100,000 white males
and 45.8 for black males, a twofold difference. This racial mortality disparity is greater than the incidence disparity. In 1969,
the rate was 21.6 per 100,000 population for white males and
33.6 for black males, demonstrating stability over 15 years in
the age-adjusted mortality for whites, while the rate increased
36% for blacks (4).

Survival Data
Mortality rates are a product of the incidence rate in previous
years and the survival rate. Survival rates depend on the stage of
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disease at diagnosis, treatment, and response to treatment, all
highly variable. Survival data, therefore, are not accurately reflected in mortality data and should be analyzed independently.
Prostate cancer accounts for nearly 11 % of cancer deaths in
males (7). The five-year survival rate for prostate cancer, adjusted for normal life expectancy, is 70% for localized disease
but only 35% for patients with distant metastases (8). Numerous
studies show that survival is related to tumor aggressiveness, the
extent and stage at which the tumor is detected, the timing and
type of treatment, as well as the willingness of the patient to follow the prescribed treatment regimen.
The SEER five-year survival rates for cases diagnosed from
1978 through 1982 for btack and white males by age and stage
of disease indicate nearly a 10% poorer overall survival rate for
black males than for white males. The survival rate for white
males of all ages and disease stages is 69.2% versus 63.3% for
black males (2).
Blacks tend to have more advanced disease at the time of discovery, indicating a delay in diagnosis and treatment. However,
survival rates for blacks are lower even when diagnosed at the
same stage of disease. A number of factors have been suggested
as influencing survival; 1) access to medical care, 2) behavioral
pattems that delay seeking treatment, 3) genetic susceptibility,
4) cultural differences, and 5) socioeconomic status (SES).
Access to medical care is related to both SES and availability
of health care. Dayal and Chiu (8) showed that apparent survival
differences attributed to race are probably due to SES differences and that the biology of the disease is apparently the same
for the two races. A study by Austin et al (9) not only revealed a
poorer survival in blacks caused by delay in seeking medical attention but also showed that young blacks had a worse survival
rate than older black or young white males. A median survival
rate of 3.9 years versus 6.0 years was found when young black
males with cancer of the prostate were compared to young white
males. The young black male delayed seeking medical attention
more than three months 72% of the time, but there was no such
delay among white males. Many black men avoid doctors because of fear of having cancer and because they wish to avoid a
possibly unpleasant cross-cultural encounter.

Epidemiologic Factors
Black American males have the highest known incidence of
prostate cancer in the world (10). Epidemiologists have sought
clues to the causes of these racial disparities (Table) but have
found no correlation between prostatic cancer and variables
such as venereal disease, smoking, alcohol, sexual habits, or occupational exposure.
High testosterone levels have been proposed as a risk factor,
as well as composition of the diet, exposure to heavy metals, and
levels of vitamin A. However, the most consistent risk factor is
age. Carcinoma of the prostate is a disease of old men. A Washington, DC, survey of prostate cancer in black men revealed that
the incidence was essentially nil in the age group 30 to 39, 5.3/
100,000 in the age group 40 to 49, but 953.5/100,000 in the age
group of 80 years old and older. The peculiar age distribution of
prostate cancer may be attributed either to an unusually long la-
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tent period or to the fact that important risk factors begin to operate late in life.
Access to medical care is a factor related more to survival
than to the incidence of prostate cancer, SES is associated with
race only in that a higher proportion of blacks have lower SES
levels. Occupational exposure may be important. Brownson et
al (11) found increased risk for farmers, mechanics, sheet metal
workers, separating machine operators, and men employed in
several manufacturing industries. The greatest risk occurs in
workers exposed to cadmium as in welding, electroplating, and
alkaline battery production. No definite relationship is reported
between prostate cancer and drinking alcohol. In fact, Jackson et
al (5) have suggested that the cirrhotic liver, unable to metabolize estrogen normally, could be protective against prostate cancer. Only one study showed any association bietween smoking
and prostate cancer.
The association between sexual activity and prostate cancer is
not clear. Reportedly the disease is more frequent and mortality
rates are higher among married men than among those who were
never married (5). Also, incidence is higher among the "common law" group than among those who are widowed, divorced,
or separated. However, other studies did not demonstrate any relationship between marital status, fertility, and prostate cancer,
A recent article suggests a relationship between vasectomy and
prostate cancer, but the numbers are small, controls poorly chosen, and no known biologic reason was offered for the cause and
effect (12). Steele et al (13) reported a positive association between prostatic cancer and sexual activity, and Jackson et al (5)
showed that prostate cancer patients were more active sexually
than were controls.
The heavy metals zinc and cadmium have long been suspected as etiologic factors. The prostate gland has a high concentration of zinc, and sexual activity lowers its zinc content.
Reportedly prostate glands with cancer or prostatitis contain
lower levels of zinc than nonneoplastic glands. Cadmium is
considered a zinc antagonist, and several studies have associated prostatic cancer with consumption of diets rich in cadmium. Oysters are an important source of this element. Increased cadmium intake may also be related to consumption of
soft drinking water that has passed through metal pipes (14,15),
A family history of cancer is commonly elicited from patients
with prostatic carcinoma, and familial aggregation has been observed repeatedly, Steele et al (13) reported that fathers and
brothers of index patients had a history of prostatic disease more
often than did relatives in control groups. Family aggregations
of the disease suggest not only a genetic relationship but also
that family members are exposed to the same environments and
diets.
In an editorial, Kovi (16) stated that the mortality rate of prostate cancer correlates positively with consumption of fats, coffee, meats, milk, and sugar, A negative correlation has been
shown with consumption of vitamin A, rich green and yellow
vegetables, cereals, pulses, and rice.
Based on mortality data and dietary pattems, Wynder et al
(17) postulated that ingestion of a diet high in fat is associated
with an increased death rate from prostatic cancer. Blair and
Fraumeni (18) reported an association t)etween high fat intake
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Table
Environmental Factors and Theories Suggested
as Related Causes of Prostate Cancer in Black Men
Environmental Factors/Theories:
Urban/Rural
Socioeconomic status
Educational attainment
Occupation (Exposure to gas or exhaust)
Alcohol
Smoking
Other Environmental Factors:
Air pollution
SO3
Dustfall soiling
BPH
Cadmium and zinc
Sexual Factors/Practices:
Marital status
Age of first ejaculation
Frequency of coitus
Number of sexual partners
Utilization of prostitutes
Abstention > 3 months
Intercourse without orgasm
Frequency of masturbation
Oral genital intercourse
Homosexual experience
Venereal disease

and the incidence of the disease. On the other hand, Mettlin (19),
studying dietary habits of blacks and whites, found data that do
not support the hypothesis that increased intake of lipid-rich
foods is related to the more frequent development of prostate
cancer.

Hormones
Much current evidence supports the concept that malignant
prostatic disorders result from androgenic stimulation. The absence of prostatic cancer in castrated men, the responsiveness of
prostatic cancer to hormone manipulation, and the evidence that
androgenic steroids can induce prostatic cancer in animal models all suggest the important role of hormones in development of
prostate cancer in men.
Because testosterone and its metabolite dihydrotestosterone
are the principal hormones affecting growth of prostate epithelial tissue, Ross et al (20) proposed that the risk of prostate cancer is determined by the cumulative exposure to circulating testosterone Evaluating black and white male students showed
that mean testosterone levels in blacks were 15% higher and free
testosterone levels were 13% higher than in whites. They suggested that the 15% difference in circulating testosterone levels
could readily explain the twofold difference in prostate risk.
When hormone levels of American blacks with prostate cancer
were compared to that of Nigerians with prostate cancer, significantly higher tevels of both testosterone and estrogens were
seen in the Americans, Ahluwalia et al (21) concluded that differences in hormone profiles of the two populations were caused
by factors other than genetic constitution alone
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Environmental factors in North America, which modify
hormone metabolism, may be important in the etiology of this
disease. There is a tenfold greater incidence of prostate cancer in
black North Americans than in black South Africans. This fact
supports the theory that life-style and dietary differences are significant factors. Studies have compared the effect of the African
vegetarian diet and the typical Westem diet on the excretion of
androgens and estrogens. With the vegetarian diet, excretion of
androgens and estrogens was decreased in black North American men, while use of the Westem diet increased the excretion
of estrogens and androgens in black South African men (22-25).
While the hormonal milieu and its modification by dietary
factors apparently influence the developing prostate cancer, genetic factors may also be involved. Recent experiments have
shown that the wild type P53 gene may have a role in suppressing prostatic tumorigenesis. Other studies have demonstrated
the loss of chromosome 17P in nearly one-fifth of clinically resected tumors, suggesting a mechanism for inactivation of the
P53 gene in human prostatic tumorigenesis. In vitro studies on
human prostatic cancer cells by Isaacs et al (26) showed that the
wild type P53 was inhibitory to DNA synthesis when compared
to action of the mutant gene. P53 mutations can be detected in
primary cancer cells as well as metastatic deposits, suggesting a
functional role for P53 as a suppressor of prostatic tumorigenesis.

Conclusions
Prostate cancer is now the leading cause of cancer deaths
among American males, affecting one of every 11 men. For
black American males, the incidence is 1 in 7. Because its incidence is increasing, there have been numerous efforts to identify
epidemiological factors. A striking feature of the epidemiology
of prostate cancer is the extreme range in incidence among racial
and ethnic groups (50% greater in blacks than in whites and 3 to
4timesgreater in blacks than in Chinese or Japanese). The reasons for such differences are unknown but are thought not to be
entirely caused by genetic predisposition.
The study of extemal factors in high-risk patients, specifically black males, may lead to the discovery of genetic and environmental interactions that cause prostate cancer.
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